4-羧基苯丙氨酸盐酸盐 | 80852-33-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-羧基苯丙氨酸盐酸盐
• 英文名称: 4-carboxyphenylalanine hydrochloride
• 英文别名: 4-Carboxyphenylalanin-hydrochlorid；4-(2-Amino-2-carboxyethyl)benzoic acid;hydrochloride
• CAS: 80852-33-1
• 化学式: C₁₀H₁₁NO₄*ClH
• 分子量: 245.663
• InChiKey: HIQWXNYWBBKVFW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.76
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  101
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-羧基苯丙氨酸盐酸盐 在 盐酸 、 4-二甲氨基吡啶 、 sodium hydroxide 、 edetate disodium 、 copper(II) sulfate 、 三乙胺 、 N,N'-二环己基碳二亚胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 25.67h， 生成 4-(benzoxycarbonyl)phenylalanine
  参考文献：
  名称：

  血管紧张素II激动剂和I型拮抗剂之间的骨架结构差异。

  摘要：

  通过固相方法制备了在位置8具有O-甲基-L-高丝氨酸[HSer（γ-OMe）]和δ-甲氧基-L-正缬氨酸[Nva（delta-OMe）]的I型血管紧张素II拮抗剂，通过反相HPLC纯化，并在大鼠子宫中进行生物测定，并通过核Overhauser效应（NOE）光谱研究了它们的骨架构象性质。[Sar1，HSer-（γ-OMe）8] ANGII，[HSer（γ-OMe）8] ANGII，[Des1，HSer（γ-OMe）8] ANGII，[Sar1，Nva（delta-OMe）8]- ANGII和[Des1，Nva（delta-OMe）8] ANGII分别具有以下拮抗剂活性pA2：7.6、7.5，<6.0、7.1和6.9。[Sar1] ANGII与δ-羟基-L-正缬氨酸[Nva（delta-OH）]，δ-甲氧基-L-正缬氨酸[Nva（delta-OMe）]，4'-羧基苯丙氨酸[Phe（4'-COO

  DOI：

  10.1021/jm00023a005
• 作为产物：
  描述：

  对氰基溴化苄 在 盐酸 、 sodium ethanolate 作用下， 反应 0.83h， 生成 4-羧基苯丙氨酸盐酸盐
  参考文献：
  名称：

  Investigation of the Active Site of Aminopeptidase A Using a Series of New Thiol-Containing Inhibitors

  摘要：

  Aminopeptidase A (APA) and aminopeptidase N (APN) are two metallopeptidases which have been suggested to be involved in the enzymatic cascade of the renin-angiotensin system. APA liberates angotensin III from angiotensin II by releasing the N-terminal aspartate, and APN participates in the inactivation of angiotensin III. As the role of angiotensin III in the regulation of blood pressure in the central nervous system and at the periphery is controversial, it was of interest to develop selective and efficient inhibitors of APA. Starting from Glu-thiol,(1) which was the first efficient APA inhibitor described, but however is equipotent on APA (K-i = 0.14 mu M) and APN (K-i = 0.12 mu M), beta-amino thiols bearing various carboxyalkyl chains have been synthesized and their inhibitory potencies measured on both purified enzymes. Compounds containing a carboxylated aromatic ring inhibited APA and APN with K-i values in the micromolar range but were slightly more active on APA. Conversely, inhibitors containing a cyclohexyl ring were more efficient on APN. Various modifications of the structure of Glu-thiol decreased inhibitory activity on both enzymes but increased the selectivity for APA, and compound 9d ((S)-4-amino-6-mercaptohexanoic acid) was 23 times more potent on APA (K-i = 2.0 mu M) than on APN (K-i = 45 mu M).

  DOI：

  10.1021/jm00035a014

文献信息

• Synthesis of bioorthogonal and crosslinking amino acids for use in peptide synthesis
  作者：G. S. M. Sundaram、Ian R. Morgan、Eric M. Tippmann

  DOI：10.1007/s00726-010-0594-3

  日期：2010.11

  syntheses and potential applications of multiple para-substituted phenylalanine derivatives comprising an isothiocyanate, α-diazoketone, or nitrone functionality. In all, three novel amino acids were synthesized in good overall yields. These non-canonical amino acids permit the further development of in vitro and in vivo chemoselective and regioselective bioconjugate reactions not possible with other

  通过遗传或化学方法将非规范氨基酸掺入蛋白质的能力使人们可以在确定的残基处将新的化学性质引入蛋白质。然后可以使用常见的有机转化来修饰这种残基。这样，可以在不干扰肽链中任何其他相邻氨基酸的情况下改变肽的结构或功能。在这里，我们描述的合成和多种潜在的应用对-取代的苯丙氨酸衍生物，其包含异硫氰酸酯，α-二氮酮或硝酮官能团。总之，以良好的总产率合成了三种新型氨基酸。这些非规范性氨基酸允许进一步发展其他试剂无法实现的体外和体内化学选择性和区域选择性生物共轭反应。
• Compounds which inhibit leukocyte adhesion mediated by VLA-4
  申请人：——

  公开号：US20040006093A1

  公开（公告）日：2004-01-08

  Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

  本发明涉及一种能够结合VLA-4的化合物。其中某些化合物还能够抑制白细胞粘附，特别是通过VLA-4介导的白细胞粘附。这些化合物在哺乳动物患者（例如人类）的炎症性疾病治疗中非常有用，例如哮喘、阿尔茨海默病、动脉硬化、艾滋病痴呆、糖尿病、炎症性肠病、类风湿性关节炎、组织移植、肿瘤转移和心肌缺血。这些化合物也可以用于治疗多发性硬化等炎症性脑部疾病。
• Wagner; Horn; Richter, Pharmazie, 1981, vol. 36, # 9, p. 597 - 603
  作者：Wagner、Horn、Richter、et al.

  DOI：——

  日期：——
• SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4
  申请人：Elan Pharmaceuticals, Inc.

  公开号：EP0994896A1

  公开（公告）日：2000-04-26
• US6583139B1
  申请人：——

  公开号：US6583139B1

  公开（公告）日：2003-06-24